Trial intelligence / Profile preview

Levobupivacaine wet wound dressing for split-thickness skin graft donor-site pain

2015-000232-15Phase 4Active

Sponsor
Hospital General Universitario de Valencia
Start
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of levobupivacaine in acute postoperative pain (2 arms), sponsored by Hospital General Universitario de Valencia. Primary endpoint: Pain intensity at 24 hours. Started Jul 2016; status: active.

02

Drugs

levobupivacaine
03

Conditions

acute postoperative pain

Beyond the preview

Go deeper on 2015-000232-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000232-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call